Phase 3 Clinical Trials

Phase 3 clinical trials are large-scale studies that test a new medical treatment's safety and effectiveness in a diverse patient population. These trials compare the new treatment to standard existing treatments or a placebo to determine how well it works and identify any side effects. They involve many participants across different locations to ensure results are reliable and applicable to the general population. Successful Phase 3 results are essential for regulatory approval, allowing the treatment to be made widely available to patients.